Back to Search
Start Over
Moderna, Excision each enter HIV battle with mRNA and CRISPR tech
- Source :
- Fiercebiotech.com. January 27, 2022
- Publication Year :
- 2022
-
Abstract
- Byline: Kyle LaHucik Moderna and Excision BioTherapeutics are stepping into a battle with HIV, a 41-year epidemic that has confuddled drug developers and vaccine makers the world over. The COVID-19 [...]
- Subjects :
- Merck & Company Inc. -- Technology application
Biological products industry -- Technology application
HIV (Viruses) -- Technology application
Vaccination -- Technology application
Messenger RNA -- Technology application
Highly active antiretroviral therapy -- Technology application
Vaccines -- Technology application
Pharmaceutical industry -- Technology application
Technology application
Biotechnology industry
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Fiercebiotech.com
- Publication Type :
- News
- Accession number :
- edsgcl.690653558